Amicus Therapeutics Inc (FOLD) Insider Trading
- $71,123,425.77
- $145,122,652.45
- Nov. 6, 2024
- John F Crowley
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 16, 2019 | CEO | 20,000 | $9.55 | Sell | $191,000.00 | |
Dec. 2, 2019 | CEO | 20,000 | $10.38 | Sell | $207,600.00 | |
Nov. 25, 2019 | CEO | 40,000 | $10.01 | Sell | $400,400.00 | |
Nov. 15, 2019 | CEO | 20,000 | $9.52 | Sell | $190,400.00 | |
Nov. 8, 2019 | CEO | 20,000 | $9.02 | Sell | $180,400.00 | |
Oct. 11, 2019 | CEO | 14,500 | $8.01 | Sell | $116,145.00 | |
Sept. 11, 2019 | CEO | 20,000 | $10.05 | Sell | $201,000.00 | |
Aug. 23, 2019 | Director | 4,945 | $10.07 | Buy | $49,796.15 | |
Aug. 1, 2019 | CEO | 20,000 | $12.54 | Sell | $250,800.00 | |
July 1, 2019 | CEO | 20,000 | $12.47 | Sell | $249,400.00 | |
June 3, 2019 | Director | 5,000 | $11.16 | Sell | $55,800.00 | |
June 3, 2019 | CEO | 20,000 | $11.15 | Sell | $223,000.00 | |
May 1, 2019 | CEO | 20,000 | $13.51 | Sell | $270,200.00 | |
April 5, 2019 | Insider | 50,000 | $14.20 | Sell | $710,000.00 | |
April 1, 2019 | CEO | 20,000 | $13.63 | Sell | $272,600.00 | |
March 1, 2019 | CEO | 20,000 | $13.60 | Sell | $272,000.00 | |
Feb. 25, 2019 | Insider | 70,000 | $12.52 | Sell | $876,400.00 | |
Feb. 1, 2019 | CEO | 20,000 | $12.12 | Sell | $242,400.00 | |
Jan. 22, 2019 | COO | 36,000 | $11.81 | Sell | $425,160.00 | |
Jan. 16, 2019 | Insider | 53,269 | $12.03 | Sell | $640,826.07 | |
Jan. 15, 2019 | CEO | 103,500 | $11.71 | Sell | $1,211,985.00 | |
Oct. 15, 2018 | CFO | 10,000 | $12.23 | Sell | $122,300.00 | |
Oct. 3, 2018 | Major Shareholder | 50,000 | $12.59 | Buy | $629,500.00 | |
Sept. 24, 2018 | Major Shareholder | 20,000 | $12.45 | Buy | $249,000.00 | |
Sept. 21, 2018 | Major Shareholder | 50,000 | $12.53 | Buy | $626,500.00 | |
Sept. 12, 2018 | Major Shareholder | 500,000 | $12.00 | Buy | $6,000,000.00 | |
July 2, 2018 | SVP | 5,000 | $15.63 | Sell | $78,150.00 | |
July 2, 2018 | CFO | 10,000 | $15.63 | Sell | $156,300.00 | |
June 1, 2018 | Insider | 25,000 | $16.72 | Sell | $418,000.00 | |
May 16, 2018 | Insider | 25,000 | $15.00 | Sell | $375,000.00 | |
May 16, 2018 | Director | 10,000 | $16.00 | Sell | $160,000.00 | |
May 14, 2018 | Insider | 5,000 | $14.04 | Sell | $70,200.00 | |
April 17, 2018 | Insider | 50,000 | $15.00 | Sell | $750,000.00 | |
April 16, 2018 | Director | 5,000 | $14.41 | Sell | $72,050.00 | |
April 12, 2018 | Insider | 5,000 | $14.72 | Sell | $73,600.00 | |
April 2, 2018 | SVP | 5,000 | $14.27 | Sell | $71,350.00 | |
April 2, 2018 | CFO | 10,000 | $14.26 | Sell | $142,600.00 | |
March 12, 2018 | Insider | 5,000 | $15.05 | Sell | $75,250.00 | |
March 9, 2018 | SVP | 8,750 | $15.00 | Sell | $131,250.00 | |
March 5, 2018 | Major Shareholder | 335,827 | $13.56 | Buy | $4,553,814.12 | |
March 1, 2018 | SVP | 8,149 | $14.06 | Sell | $114,574.94 | |
March 1, 2018 | Major Shareholder | 100,000 | $13.69 | Buy | $1,369,000.00 | |
Jan. 23, 2018 | Insider | 20,000 | $16.80 | Sell | $336,000.00 | |
Jan. 22, 2018 | COO | 32,500 | $15.92 | Sell | $517,400.00 | |
Jan. 2, 2018 | Insider | 5,000 | $14.71 | Sell | $73,550.00 | |
Jan. 2, 2018 | SVP | 8,000 | $14.72 | Sell | $117,760.00 | |
Jan. 2, 2018 | Director | 20,000 | $15.00 | Sell | $300,000.00 | |
Jan. 2, 2018 | CFO | 10,000 | $14.72 | Sell | $147,200.00 | |
Dec. 29, 2017 | CEO | 18,970 | $14.75 | Sell | $279,807.50 | |
Dec. 29, 2017 | CEO | 5,920 | $14.75 | Sell | $87,320.00 |
Insiders are both buying and selling Amicus Therapeutics Inc stock.
The insider traders at Amicus Therapeutics Inc are: John F Crowley, Bradley L Campbell, Jay Barth, Hung Do, Burke W Whitman, Daphne Quimi, William D Baird III, Perceptive Advisors Llc, Ellen Rosenberg, Jeff Castelli, Samantha Prout, Margaret G Mcglynn, Michael Raab, David Michael Clark, Life Sciences Maste Perceptive, Kenneth Peist, Jayne Gershkowitz, Glenn Sblendorio, Julie Yu, Donald J Hayden Jr, Kurt J Andrews, Plc Glaxosmithkline, Ken Valenzano, Bradley L. Campbell, Enrique Dilone, William D. Baird III, Burke W. Whitman, Dipal Doshi, Joan Winterbottom, John F. Crowley, Lynn Dorsey Bleil, and Sol J Barer
The most active insider trader at Amicus Therapeutics Inc is John F Crowley with 110 trades.
Plc Glaxosmithkline has sold the most Amicus Therapeutics Inc stock with a total value of $119,721,428.50.
Perceptive Advisors Llc has bought the most Amicus Therapeutics Inc stock with a total value of $40,474,740.62.
The most recent insider trade for Amicus Therapeutics Inc was on Nov. 6, 2024.
The single biggest insider buy for Amicus Therapeutics Inc was from Life Sciences Maste Perceptive with a total value of $18,375,000.00 on July 13, 2017.
The single biggest insider sell for Amicus Therapeutics Inc was from Plc Glaxosmithkline with a total value of $59,860,714.25 on Oct. 27, 2014.